Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121591464 | 12159146 | 4 | F | 20160219 | 20160718 | 20160308 | 20160728 | EXP | PHEH2016US004639 | NOVARTIS | 62.52 | YR | M | Y | 0.00000 | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121591464 | 12159146 | 1 | PS | ENTRESTO | SACUBITRILVALSARTAN | 1 | Oral | 50 (24/26) MG, UNK | 207620 | 50 | MG | BID | |||||||
| 121591464 | 12159146 | 2 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | U | 0 | ||||||||||
| 121591464 | 12159146 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | UNK, BID | U | 0 | BID | ||||||||
| 121591464 | 12159146 | 4 | C | FISH OIL | FISH OIL | 1 | Unknown | U | 0 | ||||||||||
| 121591464 | 12159146 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | U | 0 | ||||||||||
| 121591464 | 12159146 | 6 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | Unknown | U | 0 | ||||||||||
| 121591464 | 12159146 | 7 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | U | 0 | ||||||||||
| 121591464 | 12159146 | 8 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121591464 | 12159146 | 1 | Cardiac failure |
| 121591464 | 12159146 | 2 | Product used for unknown indication |
| 121591464 | 12159146 | 3 | Product used for unknown indication |
| 121591464 | 12159146 | 4 | Product used for unknown indication |
| 121591464 | 12159146 | 5 | Product used for unknown indication |
| 121591464 | 12159146 | 6 | Product used for unknown indication |
| 121591464 | 12159146 | 7 | Product used for unknown indication |
| 121591464 | 12159146 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121591464 | 12159146 | OT |
| 121591464 | 12159146 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121591464 | 12159146 | Asthenia | |
| 121591464 | 12159146 | Dizziness | |
| 121591464 | 12159146 | Fall | |
| 121591464 | 12159146 | Haemorrhage | |
| 121591464 | 12159146 | Head injury | |
| 121591464 | 12159146 | Inappropriate schedule of drug administration | |
| 121591464 | 12159146 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121591464 | 12159146 | 1 | 20160208 | 0 |